KaloBios Pharmaceuticals Inc., the company that fired ex-Chief Executive Martin Shkreli after he was arrested for securities fraud, is still in talks to buy a drug that treats Chagas disease. The Wall Street Journal has the Daily Bankruptcy Review article here.
[more]